Αρχική World News Combining Enzalutamide with Radium-223 Significantly Improves rPFS as First-Line Therapy for Patients... World News Combining Enzalutamide with Radium-223 Significantly Improves rPFS as First-Line Therapy for Patients with mCRPC Από Ogkologos - 27 Αυγούστου, 2025 617 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PEACE-3 study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR EMA Recommends Granting a Marketing Authorisation for Generic Trabectedin 30 Απριλίου, 2025 Heartburn Medications Pulled From Shelves Because They May Cause Cancer 13 Ιανουαρίου, 2020 Prostate Cancer Prevention and Finasteride: A Conversation with NCI’s Dr. Howard... 13 Μαΐου, 2019 Identification of Potential Biomarkers for Clinical Benefit Following Dual Neoadjuvant Anti-HER2... 8 Μαΐου, 2021 Φόρτωση περισσοτέρων HOT NEWS A Combination of Amivantamab and Lazertinib Shows Durable Clinical Activity in... Improving cancer care for the LGBTQ+ community First-Line Treatment with Ribociclib plus Letrozole Shows a Significant Overall Survival... How to Talk to Your Kids About Ways to Prevent Cancer